However, MGMT expression is not the sole determinant of TMZ sensitivity [15–18] and IDH1 mutant and wild-type gliomas have different molecular ontogenies, making comparisons between IDH1 mutant and wild type gliomas uninformative as to which tumor characteristics can be attributed directly to IDH1 mutation. The gene discussed is IDH1; the disease is glioma.